文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

2012-2020年全球麻疹和风疹战略计划中期审查

Measles and Rubella Global Strategic Plan 2012-2020 midterm review.
PubMed 文献 · Vaccine · 2018-01-01

该中期审查评估了《2012-2020年全球麻疹和风疹战略计划》的实施情况,指出消除麻疹是最终目标但设定日期为时过早,现有区域消除目标应大力推进以便到2020年设定全球目标;报告建议从主要依赖补充免疫活动转向主要依赖持续服务确保两剂含麻疹疫苗的接种,从主要依赖覆盖率转向将疾病发病率作为主要指标,并加速将风疹疫苗接种纳入免疫规划。

要点

  • 消除麻疹是最终目标但设定日期为时过早,现有区域消除目标应大力推进以便到2020年设定全球目标。
  • 建议从主要依赖补充免疫活动转向主要依赖持续服务确保两剂含麻疹疫苗接种,持续强化服务期间仍需定期高质量补充免疫活动。
  • 建议将麻疹/风疹疫苗接种规划视为整体免疫规划质量的指标,并将麻疹/风疹发病率和麻疹及风疹疫苗接种覆盖率作为免疫规划绩效的主要指标。

核心结论

  • 消除麻疹是最终目标但设定日期为时过早,现有区域消除目标应大力推进以便到2020年设定全球目标。
  • 《2012-2020年全球麻疹和风疹战略计划》中阐述的基本战略方法是实现目标的有效方法但尚未完全实施或未适当适应当地情况。

研究设计与样本

  • 该文为《2012-2020年全球麻疹和风疹战略计划》的中期审查报告。

主要发现

  • 报告建议从主要依赖补充免疫活动转向主要依赖持续服务确保目标人群接种两剂含麻疹疫苗,持续强化服务期间仍需定期高质量补充免疫活动。
  • 报告建议从主要依赖覆盖率衡量进展转向将疾病发病率作为主要指标。
  • 报告建议将麻疹/风疹疫苗接种规划视为整体免疫规划质量的指标,并将麻疹/风疹发病率和麻疹及风疹疫苗接种覆盖率作为免疫规划绩效的主要指标。
  • 脊髓灰质炎过渡既带来风险也带来机遇,应最小化风险并最大化机遇。
  • 入学时免疫检查可显著加强整体免疫服务,确保已接种推荐剂量的麻疹和风疹疫苗及其他疫苗,并在儿童未接种或接种不足时提供这些疫苗。

临床怎么用

  • 报告建议从主要依赖补充免疫活动转向主要依赖持续服务确保两剂含麻疹疫苗接种,持续强化服务期间仍需定期高质量补充免疫活动。
  • 报告建议将疾病发病率作为衡量进展的主要指标,并将麻疹/风疹发病率和麻疹及风疹疫苗接种覆盖率作为免疫规划绩效的主要指标。
  • 报告建议考虑将麻疹/风疹疫苗接种规划作为整体免疫规划质量的指标。
  • 报告建议入学时免疫检查可显著加强整体免疫服务,确保推荐剂量的麻疹和风疹疫苗及其他疫苗已接种,并在儿童未接种或接种不足时提供这些疫苗。
  • 报告建议规划决策应 increasingly 基于高质量数据和适当分析,并加速将风疹疫苗接种纳入免疫规划,给予与麻疹同等重视。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

1. Measles eradication is the ultimate goal but it is premature to set a date for its accomplishment. Existing regional elimination goals should be vigorously pursued to enable setting a global target by 2020. 2. The basic strategic approaches articulated in the Global Measles and Rubella Strategic Plan 2012-2020 are valid to achieve the goals but have not been fully implemented (or not appropriately adapted to local situations). 3. The report recommends a shift from primary reliance on supplementary immunization activities (SIAs) to assure two doses of measles-containing vaccine (MCV) are delivered to the target population to primary reliance on ongoing services to assure administration of two doses of MCV. Regular high quality SIAs will still be necessary while ongoing services are being strengthened. 4. The report recommends a shift from primary reliance on coverage to measure progress to incorporating disease incidence as a major indicator. 5. The report recommends that the measles/rubella vaccination program be considered an indicator for the quality of the overall immunization program and that measles/rubella incidence and measles and rubella vaccination coverage be considered as primary indicators of immunization program performance. 6. Polio transition presents both risks and opportunities: risks should be minimized and opportunities maximized. 7. A school entry immunization check could contribute significantly to strengthening overall immunization services with assurance that recommended doses of measles and rubella vaccines as well as other vaccines have been delivered and providing those vaccines at that time if the child is un- or under-vaccinated. 8. Program decisions should increasingly be based on good quality data and appropriate analysis. 9. The incorporation of rubella vaccination into the immunization program needs to be accelerated - it should be accorded equivalent emphasis as measles. 10. Outbreak investigation and response are critical but the most important thing is to prevent outbreaks.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Orenstein WA, Hinman A, Nkowane B, et al. Measles and Rubella Global Strategic Plan 2012-2020 midterm review. Vaccine. 2018. PMID: 29307367. doi:10.1016/j.vaccine.2017.09.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。